XML 38 R26.htm IDEA: XBRL DOCUMENT
v3.23.1

Significant Transactions (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Viridian Sciences Inc. [Member] |
Business Acquisition [Line Items] |
Schedule of estimated acquisition date fair value of consideration |
Shares issued |  | $ | 6,186 |
Contingent consideration |  |  | 2 |
Total fair value of consideration transferred |  | $ | 6,188 |
Schedule of preliminary estimated fair values of assets acquired and liabilities |
Accounts receivable |  | $ | 556 |
Prepaid expenses and other current assets |  |  | 148 |
Capitalized software |  |  | 423 |
Acquired technology |  |  | 470 |
Customer relationships |  |  | 820 |
Acquired trade name |  |  | 20 |
Goodwill |  |  | 5,408 |
Accounts payable and accrued expenses |  |  | (350 | )
Deferred tax liabilities |  |  | (307 | )
Deferred revenue |  |  | (1,000 | )
Net assets acquired |  | $ | 6,188 |
365 Cannabis [Member] |
Business Acquisition [Line Items] |
Schedule of estimated acquisition date fair value of consideration |
Shares issued |  | $ | 11,060 |
Cash |  |  | 4,982 |
Contingent consideration |  |  | 6,300 |
Total fair value of consideration transferred |  | $ | 22,342 |
Schedule of preliminary estimated fair values of assets acquired and liabilities |
Cash |  |  | 527 |
Accounts receivable |  |  | 486 |
Prepaid expenses and other current asset |  |  | 261 |
Fixed Assets |  |  | 93 |
Non-compete agreement |  |  | 80 |
Acquired technology |  |  | 1,040 |
Customer relationships |  |  | 13,810 |
Acquired trade name |  |  | 270 |
Goodwill |  |  | 12,489 |
Accounts payable and accrued expenses |  |  | (2,588 | )
Deferred tax liabilities |  |  | (826 | )
Deferred revenue |  |  | (3,300 | )
Net assets acquired |  | $ | 22,342 |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=kern_ViridianSciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=kern_ThreeSixtyFiveCannabisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |